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Abstract 
Nowadays environmental and climate issues have brought the topic of bioeconomy to 
the political agenda around the world. Plant-based bioeconomy (pBE) has a key role in 
securing sustainable supplies of energy, food and raw materials for increasingly aging 
and growing societies. However, the technological roots and development path of pBE 
are far from being fully understood. Accordingly, we seek to contribute to an in-depth 
understanding of how biotechnology innovations affected the emergence of 
bioeconomy by exploring the technological field evolution of plant-based patent 
applications between 1995 and 2015 in Germany. We employ patent citation data and 
conduct forward citation analysis to trace technological trajectories within plant-based 
biotechnology. We extend previous work by combining patent-based citation analysis 
with text-mining approach. Main path analysis allows the identification of main players 
within plant-based biotechnology over time. Our explorations reveal dominant and also 
peripheral technologies within the sphere of plant-based applications and provide us in 
this way with a more comprehensive understanding of the field´s technological 
evolution. Our findings suggest a transition from basic biotechnological research 
towards more sustainability- and medicine-related technological orientation in the field. 
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Today, the world is facing some fundamental societal challenges such as 
demographic change, food shortages and further environmental issues. These 
developments and the urgent search for potential solutions brought the topic of 
bioeconomy to the political agenda. For example, the National Research Strategy 
BioEconomy of the German Federal Ministry of Education and Research aims to achieve 
a more efficient use of biological resources by 2030. EU Research and Innovation 
Program Horizon 2020 considers bioeconomy to be the answer to various environmental 
challenges and points its aim as “production of renewable resources (...) and their 
conversion into (…) bio-based products and bio-energy”.  
The breadth of bioeconomy as a scientific field and societal concept is enormous. 
Bio-based developments enhance commercial applications in chemistry, engineering, 
pharmaceutical and food industry. When thinking about renewable resources, used in 
bioeconomy production, plant compounds are usually put forward as its most probable 
source. One highly influential technological root of this emerging field can be found in 
biotechnological innovation processes, particularly those dealing with plant usage and 
breeding. Accordingly, for the purpose of this paper we focus on the plant-based 
bioeconomy. Plant components here are considered in a broader sense, encompassing 
different sugars, oils, fats and pigments (Lewandowski, 2017). As such, the case of plant-
based bioeconomy provides a rich field to study the transition from biotechnology 
(especially “green biotechnology”) towards bioeconomy.  
The contemporary political and scientific discussion points to the fact that plant-
based bioeconomy (pBE) becomes more and more important in securing sustainable 
supplies of energy, food and raw materials for increasingly aging and growing societies 
and changing climatic conditions. With the help of the renewable resources bioeconomy 
may decrease or even eliminate dependence on fossil fuels and thus release the burden 
on the environment (BMBF, 2014). However, technological roots and the development 
path of pBE are far from being fully understood. National Research Strategy BioEconomy 
2030 of German Federal Government outlines, that “…A combination of approaches in 
breeding, plant biotechnology, and other disciplines will be necessary to provide 
technical solutions for these requirements”, thus pointing out the role of biotechnology 
research in this transformation (BMBF, 2011). To the best of our knowledge, no 
longitudinal empirical analysis on the transition from biotech to bioeconomy has been 
conducted so far. 
Apart from that, it is yet not clear, what technologies exactly can be seen as 
bioeconomy-related. Although several policy documents clearly state the importance of 
biotechnology applications for this societal area, not all subfields of biotech seem to be 
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welcome in this new field. According to some visions (e.g. bio-ecology vision, outlined in 
Bugge et al., 2016, which focuses on ethical issues and organic agriculture), such 
important biotechnology developments as transgenic crops cannot be included in 
bioeconomy (Bugge et al., 2016). Therefore, understanding of the dominant 
technological paths within biotechnology helps to reveal, whether more weight is added 
to sustainability topics over time, which will signal the transition to bioeconomy. Taking 
into account issues stated above as well as the importance of bioeconomy for 
sustainability agenda, an in-depth understanding of the field is important for both 
managers and political decision makers alike. Hence, in this paper we seek to explore 
the technological field evolution of biotechnology from various angles in order to answer 
the following research question: do we observe a transition from biotechnology towards 
bioeconomy on the example of pBE1? 
To do so, we compile a unique data set for the German biotech industry, covering 
a period of 20 years (1995-2015), along the cycle of industry development, from the 
initiation in mid 90s to the last year, for which patent population could be constructed. 
The dataset covers the full set of all plant-based biotechnology (pBT) patents and all 
direct forward citations.  
There are several good reasons for focusing on the German case. First, the 
pharmaceutical and chemical industry, strongly involved in biotechnological research, 
have a longstanding tradition in Germany. Second, funding schemes – promoting the 
emergence of biotechnology as an entirely new technological field – were initiated and 
continuously supported by the Federal Ministry of Education and Science (BMBF) in the 
mid-90s. Third, the German scientific landscape is characterized by high density of 
universities, applied universities and research institutions covering the full spectrum from 
applied research (e.g. Fraunhofer Society) to basic research (e.g. Max Planck Society). 
This, in turn, provides a fertile ground for the emergence of bioeconomy.  
To gain an in-depth understanding of the technological transition from biotech to 
bioeconomy in Germany, we apply a three-stage research design. In line with Verspagen 
(2007), Nomaler, Verspagen (2016) and Fontana et al. (2009), we reconstruct the 
technological landscape of biotechnology based on patent application data by using a 
graph theoretical approach. In addition, we include direct patent citation data to account 
for a broader range of bio-related patents. This, in turn, allows us to gain a 
comprehensive picture of the technological field of biotech and beyond. We employ 
network analysis methods on direct graphs to measure and analyze the system’s 
topology from various angles and identify main paths and peripheral areas. Finally, we 
combine our empirical network approach with a content-related text mining analysis. 
                                               
 
1 Although the definition of bioeconomy is rather broad and it stems not only from biotechnology, but also 
from other fields, including agriculture, waste disposal etc. In this paper, however, we are limiting ourselves 
to the part of bioeconomy, coming from plant biotechnology. 
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Latter allows looking deeper in context dimension of chosen patents and understand 
deeper where the field is going. 
The remainder of the paper is organized as follows: we start in section 2 with 
some theoretical considerations and an assessment of the literature on technological 
trajectories as well as the main path identification. Next, we introduce the German 
biotechnology and provides an overview of the data and methodology used for the 
purpose of this paper. Section 4 provides the results of our empirical analyses. The paper 
ends with a discussion of our key findings, limitations and concluding remarks. 
2. Theoretical background and state of the art 
Within the scope of neoclassical economics firms are typically considered as a 
black box in which production processes takes place under fixed technology and against 
the backdrop of a highly idealized set of assumptions. It was Schumpeter (1912, 1939) 
who emphasized the role of innovation and technological advancements as the main 
driver of economic change and prosperity (Witt, 2008). Schumpeter was convinced that 
economic change is generated within the economic system and that there must be some 
kind of inherent force – today typically referred to as innovations - that destroys every 
equilibrium state (Hanusch and Pyka 2007).  
This notion was embraced several years later and initiated the emergence of a 
new and influential strand of economics (Nelson and Winter 1974, 1982), known as 
evolutionary economics or neo-Schumpeterian school of thought. This approach differs 
in various aspects from mainstream economics. First, economic actors are considered 
to be heterogeneous, bounded rational agents following individual strategies, which are 
rather the result of trial-and error heuristics than fully rational and deterministic 
optimization procedures. Second, knowledge and learning become main cornerstones 
of the approach. It’s the agents’ ability to generate novelty that allows them to cope with 
uncertainty and complexity in highly volatile and rapidly changing environments. Third, 
market equilibria are rather an exception than the rule. Hence, the status quo is typically 
highly fragile and endogenous drivers – e.g. entrepreneurs or established companies 
initiating radically new ideas – fuel the ongoing systemic change. Finally, technological 
developments at higher aggregation levels mirror the individual innovation efforts of 
actors at the micro level. Literature in this field shows that technological change 
processes are context-specific (Boschma 2005), path-dependent (Arthur, 1989; David, 
1985) and cumulative in nature (Dosi, Grazzi, 2010), as they are building upon previous 
experience, successes and failures. As a consequence, the destruction or radical change 
of existing industries due to technological progress is considered from a neo-
Schumpeterian perspective to be a natural constituent of an economy.  
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For the purpose of this paper, we are particularly interested in the structural 
dimension of technological change. The literature on technological paradigms (Dosi, 
1982, Dosi et al. 1988) provides a fertile ground to analyze how path-dependent 
innovation processes at the micro-level shape the emergence and structuration of 
technological landscapes. The technological paradigm here is seen as a “model” and a 
“pattern” of solution of selected technological principles (Dosi, 1982). The selective and 
cumulative character of paradigm is reflected by technological trajectories as “the path 
of improvement taken by technology” within it. (Dosi & Nelson, 1994).  
Besides these mostly conceptual contributions, a rich body of empirical and 
methodological literature emerged over the past years and enhanced our understanding 
of how and why technological change occurs. Patent data and publication data turned 
out to be highly valuable in this context. For instance, Verspagen (2007) and Fontana et 
al. (2009) used patent data for analyzing technological graphs, since patent documents 
contain a broad range of information about technological characteristics of an invention, 
thus providing knowledge embedded in it. At the same time, the studies of Hummon and 
Doreian (1989) and Liu, Lu (2012) demonstrate that bibliometric data has a high potential 
to gain comprehensive insights on technological change as well. 
Thus, several authors have applied the idea of technological trajectories in order 
to identify main paths of development within a specific industry with the help of patent 
data. Most notably, the seminal paper of Hummon and Doreian (1989) paved the way 
for a number of follow-up studies by exploring the developments in DNA research. This 
triggered series of empirical studies, which can be grouped into three overlapping 
streams.   
The first stream of literature uses main path analysis to describe the 
developments within important societal areas. To start with, Verspagen (2007) depicted 
technological trajectories in fuel cells research. He asks, whether there is a convergence 
within technological space. The results along the network of main paths confirm a 
selective character of technological trajectories within the field. The work of Fontana et 
al. (2009) extended previous research by providing a fine-grained exploration of 
technological paths using the example of Ethernet. The findings of the conducted main 
path analysis confirmed the initial predictions of experts from economics and 
engineering. One specific advancement contributed by Fontana et al. (2009) is the 
identification of several distinct subsequent stages along with main path development. 
Mina et al. (2006) enriched the literature by investigating co-evolutionary processes in 
medical research by exploring two complementary datasets, namely patent data and 
bibliometric data. 
The second stream of literature focuses on methodological and technical 
improvements of the main path analysis and contributes significantly to a critical 
assessment of previous research. Barbera-Tomas et al. (2011) checked the reliability of 
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connectivity analysis by implementing and conducting external and internal validation 
procedures based on artificial disc patents data. Connectivity analysis shows that the 
main path contains reliable knowledge of the field. Liu, Lu (2012) in turn, focused on 
citation graphs of scientific research papers, dealing with the Hirsch index. The authors 
distinguish between ‘local’ and ‘global’ main paths. They show empirically that the global 
main path, which has the overall largest traversal count, has to be calculated in order to 
identify the overall importance of the knowledge flow. One more alternative approach is 
proposed by Park and Magee (2017), who introduced genetic backward-forward path 
analysis. This method is based on identifying high persistence patents, which preserve 
important knowledge of the field. As a result, network complexity may be decreased with 
dominant knowledge not being lost. 
Finally, within the third stream of literature previous technology-centered 
contributions are extended by applying the main path methodology to other related 
themes. Most notably Nomaler and Verspagen (2016) applied an evolutionary economic 
perspective and analyzed first and second-order citations across county boundaries 
within the US. The main research interest here lied in investigating under which 
conditions knowledge flows globally or locally. Results showed the co-existence of 
technological clustering in regions and turned attention to the necessity of connecting 
locally embedded knowledge via cross-spanning ties. 
In this paper, we contribute to the above-outlined literature in at least two ways. 
On the one hand, to the best of our knowledge, we are the first to go outside the borders 
of one field and look at the societally initialized normative paradigm change. In doing so, 
we extend our knowledge of the transition process in a highly topical and relevant 
technological field. Here transition towards sustainability plays a central role. On the 
other hand, we complement the methodological toolbox by combining well-established 
network analysis methods for main path analysis with content-based analysis via using 
text mining tools. Whereas network analysis in that sense helps us to identify the most 
influential patents, text-mining tools help to dive deeper in the context of given 
applications. 
3. Technology, data and methods 
3.1. Plant-based biotechnology in Germany 
The intensification of research and development as well as the beginning of 
commercial use of pBT dates back to the early 1970s. In 1973 the r-DNA technique was 
invented (Parayil, 2003). In the following year, 1974, the first patent related to 
biotechnology was applied for. The patent dealt with the topic of genetic manipulations 
(Feldman, 2000). The 1980s were characterized by increased interactions between 
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scientific and commercial sides of the industries. Large biotechnology corporations 
intensified their investments in research on transgenic organisms by using constantly 
advancing scientific and technological base (Parayil, 2003).  
However, all the initial developments in biotechnology in general – and in pBT in 
particular – took place in the US. The first noteworthy developments in the field of 
biotechnology in Europe date back to the early 1990s. Firstly, the period was 
distinguished by improvement of the legislation in the field of genetic research: regulatory 
regime for the work of genetic laboratories was introduced along with the legislation by 
European Union on authorization of medical products (Kaiser, Prange, 2003; Häussler, 
2007). Apart from that, research and development activities were strongly supported by 
several federal programs. In Germany these programs included BioRegio Competition 
and BioProfile targeting particular regions and BioChance opting at the support of 
particular projects. These opportunities of financial support led to the founding of many 
SMEs, which – alongside with established biotech and pharmaceutical companies – 
constitute the core of German biotechnology.  
Nevertheless, not all operating fields of biotechnology have received equal 
support and development. Whereas red (medicine-related) and white (industry-related) 
biotechnology were not restricted in their development, green (agricultural) subfield was 
lagging behind. The reason for that is the extensive inventions, which relate to genetically 
modified plants, which the EU is negative about (Székács, 2017). These open systems, 
according to Székács (2017), relate to openness to environment, e.g. to agriculture or 
fishery. Apart from that, the differences between four generations of GM crops are of 
high importance here. Whereas the first generation relates mostly to the use of 
pesticides, second deals with improvement or modification of plants qualities, third deals 
with industrial and pharmaceutical products and fourth produced with new methods in 
molecular biology (Székács, 2017). Thus, newer generations of genetic crops may be 
looked at more favorably from the EU perspective. 
In this context, it is important to emphasize that green biotechnology, as well as 
the white one, are exactly the fields where most of the potential for sustainable 
development is hidden (McCormick & Kautto, 2013). Many authors consider 
biotechnology to be an important predecessor and the source of bioeconomy (Bugge et 
al., 2016). This notion is also supported by several policy documents and initiatives 
initiated on different levels. According to the National Research Strategy BioEconomy 
2030 of German Federal Government: “… A combination of approaches in breeding, 
plant biotechnology, and other disciplines will be necessary to provide technical solutions 
for these requirements. This includes not only methods such as genome analysis – 
including epigenetic studies, proteomic- and metabolomic research, bioinformatics, and 
the system-biological integration of these approaches – but also the responsible 
application of genetic engineering” (BMBF, 2011). Apart from that, the importance of 
biotechnology inventions for bioeconomy introduction was voiced by OECD (2009).  
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Despite the role of biotechnology in bioeconomy establishment, the issue of GM 
crops usage is still far from being clear. Some more ethically-oriented (bio-ecology) 
visions of bioeconomy exclude GM plants from it (Bugge et al., 2016). Furthermore, the 
replacement of fossil fuels with biomass may lead to other environmental problems, such 
as land erosion or biodiversity loss, which is critically seen by some NGOs (McCormick, 
Kautto, 2013). All these things call for the necessity of the identification of how 
biotechnology is developing and distinguishing the ones, which can be related to 
bioeconomy.  
So where does the field of pBT go in Germany? How is the conflict between set 
goals towards necessity of providing nutrition and ethical concerns are resolved? Do 
other connected fields (medicine, chemical engineering etc.) influence this new field? 
These questions are going to be answered within the following subchapters of this article. 
3.2. Data 
Data used for further analysis comes from several sources. Patent data used in 
the paper was taken from PATSTAT Database, Version Autumn 2017. PATSTAT 
presents consolidated data on patents, registered in different patent offices around the 
world. Apart from that, applicant/inventor data along with information on technological 
spheres related to each particular patent is provided. PATSTAT also allows to track 
forward and backward citations of selected patents.  
The information on firm attributes, such as funding date, turnover, number of 
employees as well as the ownership data was taken from the ORBIS database, which 
provides a broad range of firm information. Data stem from various sources (e.g. from 
Creditreform, Handelsregister etc.). In the scope of this paper, such kind of data is used 
only when analyzing the attributes of the applicants/inventors, who contributed to the 
field. 
One relevant initial issue is the identification of patent classes related to pBT. The 
choice of the relevant patent classes, was performed as follows. Firstly, the IPC classes 
which were considered as biotechnology by either OECD (2009) or WIPO (2008) or both 
were taken2. Secondly, these classes were analyzed in order to isolate plant-related 
classes within the full set of biotechnology patents. As international patent classification 
has a rather detailed structure, this could be realized by looking at the title of relevant 
classes, subclasses, main groups or subgroups and filtering out those where the term 
“plant” appears. Thus, following units of IPC could be identified as being pBT: A01H 1*, 
                                               
 
2 This means following IPC classes: A01 H1/00, A01 H4/00, A61 K38 /00, A61 K39 /00, A61 K48 /00, C02 
F3/34, C07 G, C07 K, C12 M, C12 N, C12 P, C12 Q, C12 R, C12 S, G01 N27 /327, G01 N33 / (53 *, 54 *, 
55 *, 57 *, 68 ,74 ,76 ,78 ,88 ,92) as well as later added C40B 40/00 - 50/18, C40B 70/00 - 80/00, C40B 
10/00. Later classes can be found in Eurostat indicators on High-tech industry and Knowledge. 
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A01H 4*, A61K 38/56, C07K 4/10, C07K 14/415, C07K 16/16, C12M 3*, C12N 5/04, 
C12N 5/14, C12N 9/32, C12N 15/05, C12N 15/29, C12N 15/82, C12Q 1/6895.  
Finally, we check this initial choice by analyzing titles and abstracts of 
biotechnology classes. To proof that this method gives reliable results, we have screened 
abstracts and titles of patents in order to count, in which biotechnology classes term 
“plant” appears at most. We are counting patent families, filed between 1995 and 2015 
by German applicants or inventors. Here we follow the procedure offered by Parisi et al. 
(2012). However, as we are interested in the subfield in general and not in its specific 
technologies, no extra keywords were added. As a result of this keyword search, the 
initially identified classes could be supported. The unconditional leader of pBT patent 
classes is the main group C12N 15/82 - Mutation or genetic engineering; DNA or RNA 
concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or 
purification; Use of hosts therefor… Vectors or expression systems specially adapted for 
eukaryotic hosts … for plant cells. Apart from that, many plant-related patents are 
included in classes C12N 5/10, C12N 15/09, A01H 1/00, C12N 15/29, A01H 4/00, C12Q 
1/68. Some of these classes however are rather broad and include many patents, only 
some of which by coincidence or for a reason include “plant” in them. Thus, for example, 
the class C12N 5/10 - Microorganisms or enzymes; Compositions thereof…  
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or 
maintenance thereof; Culture media therefor… Cells modified by introduction of foreign 
genetic material, e.g. virus-transformed cells have more than 10000 patents for the 
period, where the term “plant” appears in the abstract or in the title. However, in relative 
terms these patents constitute less than 10% of the overall number of patent applications 
in this class. Thus, it was not taken into consideration. After filtering out such classes, as 
well as the ones where less than 100 patents were applied for during the observation 
period3, the following classes were taken into consideration: A01H 1*, A01H 4*, A61K 
38/56, C07K 4/10, C07K 14/415, C07K 16/16, C12M 3*, C12N 5*, C12N 9/32, C12N 
15/05, C12N 15/29,  C12N 15/82, C12Q 1/68954. 
3.3. Sample identification 
After sorting out pBT patent classes, a sample population, which was later used 
for analysis, was constructed. Accordingly, chosen patents should have their earliest 
filing date between 1995 and 2015, with 1995 being taken as the approximate initiation 
of biotechnology in Germany, while 2015 is the latest year, for which the PATSTAT 2017 
Autumn edition provides whole patent coverage. Apart from that, as we are interested in 
the German pBT, at least one actor (applicant or inventor), who is related to the patent, 
should be based in Germany. Being genuinely interested in the flows of knowledge, we 
                                               
 
3 As it is hard to drive conclusions about the relatedness of the class to pBT basing only on the small amount 
of patents. 
4 Titles of respective patent classes are provided in Appendix A.  
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do not differentiate between applicants and inventors. Thus, we do not miss important 
patents from individuals, or patents, performed inside of German organizations by 
individuals, based elsewhere.  
As the focal aim of this paper lies in covering what is happening within pBT in 
Germany, an additional filter was put on place of patent registration. Thus, only German, 
European and International patents were taken into account. This helped us to get rid of 
the possible strategic patenting or corporations, creating something specifically for a 
particular market, which may not reflect real German pBT development. Apart from that, 
we have focused on the level of DOCDB simple patent family5. According to the 
European Patent Office, patents, belonging to one patent family, cover a single invention 
(EPO, 2017). Good example for it is an invention, which is subsequently registered in 
different countries. These patents, however, have one priority filing date, which is the 
subject to our interest. After applying these filters, we have obtained sample of 1434 
patent families. 
Next, citations to these patents were collected. As well as the focal patents, 
citations should have at least one inventor or applicant, who is based in Germany and 
be registered at the German, European or International patent office. As the result, 1682 
patent families were identified. 
3.4. Main path analysis 
The analytical part of the paper is based on the ‘main path analysis’ method, 
originally proposed by Hummon and Doreian (1989). The method allows identification of 
dominant trends with the help of directed graphs. Mina et al. (2007) applied the main 
path analysis to show the existence of main paths in the case of Coronary artery disease. 
Verspargen (2007) analyzed technological evolution in the field of fuel cell technology. 
Fontana et. al (2009) complemented this strand of research by providing new evidence 
on technological change patterns in LAN technology. Liu, Lu (2012) extended the 
analysis by choosing Hirsch Index as a field of interest. This method was applied in more 
or less stylized way by Park, Magee (2017), No, Park (2010) and others. 
The key idea of Hummon and Doreian (1989) was to find a systematic way of 
tracing the main streams of field evolution in a graph. In the case of patent data, each 
vertex of the graph represents a single patent while the edges stand for citations. Thus, 
main path on patent data allows for the identification of the dominant 
trajectory/trajectories, representing the most distinct strand of innovations in a well-
specified technological field. Graphs typically show a highly complex structure. Hence, 
                                               
 
5 We are using earliest filing date (the filing date of priority filing) for our analysis, as it is the year of 
knowledge generation. Apart from that, as we are interested in the process of knowledge diffusion, we are 
focusing on patent applications. 
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the identification of several dominant paths is not uncommon (Verspagen, 2007). To 
identify and isolate the main path, several measures were introduced and discussed in 
the pertinent literature, typically referred to as ‘traversal counts’. The idea behind these 
measures is straight forward. They are designed to measure the connectivity between 
vertices in a graph. Hummon and Doreian (1989) proposed three of these measures: 
 node pair projection count (NPPC), reflecting the number of times the link is 
connecting all possible node pairs. The drawback of this indicator is the 
overestimation of the points in the middle. Apart from that, here a specific 
subnetwork with start and end nodes is implied (Liu, Lu, 2012). This algorithm is 
not applied when analyzing large graphs (Batagelj, 2003). 
 search path link count (SPLC), defining the number of times the link appears on 
all possible search paths, from each node to each end node. The drawback of 
the indicator can be seen in assigning later links higher values because of them 
being counted several times (Triulzi, 2011), thus it can be used only when the 
importance of initial nodes is low (De Nooy et al., 2005); 
 search path node pair (SPNP), counting all node pairs, connected by a link. The 
drawback here is the overestimation of the middle-located nodes (Triulzi, 2011). 
These measures were further extended e.g. by forward citation node pair (FCNP), 
defined as product of forward citations of two connected nodes (Choi, Park, 2009). The 
most used index, however, was introduced by Batagelj (2003). This measure is called 
search path count (SPC). It is calculated by counting the number of paths that a particular 
path connects, trying to eliminate thus disadvantages of SPNP and SPLC. The latter 
index along with SPNP and SPLC was implemented in main path identification technique 
of the Pajek software, which allows reducing large graphs. After considering all pros and 
cons with regards to the research question, we thus apply SPC for main path analysis. 
Apart from the difference between several measures, one should also 
differentiate between global and local main paths. By the local main path method, the 
highest traversal count is chosen on every step (with “step” meaning new starting point), 
which does not mean that the local main path receives the highest overall traversal count. 
The latter is exactly depicted by the global main path (Liu, Lu, 2012). Two specifications 
may but should not lead to identical results. As Liu and Lu (2012) mention that global 
path can be used for the identification of the most important flow of thoughts overall, 
whereas local main path emphasizes the important technologies’ progress over separate 
periods. Apart from these well-established methods, key-route was proposed by Liu and 
Lu (2012) as an alternative. Its peculiarity is that a defined number of top links should be 
included in a corresponding path. As we are trying to follow a step-by-step transition of 
the one field into another, local main path is put forward. 
13/41 
 
#2002 Bremen Papers on Economics & Innovation 
 
From biotech to bioeconomy 
New empirical evidence on the technological transition to plant-based bioeconomy based on patent 
data 
 
When it comes to local main path, forward and backward options can be 
distinguished. As Liu and Lu (2012) mention, forward main path can help to identify from 
where important patents from the past come, whereas backwards search provides 
origins of the currently important patents. Apart from that, Park and Magee (2017) 
combine both methods by introducing genetic backward-forward path analysis, which is 
based on identifying high persistence patents, which preserve important knowledge of 
the field. Basing on our research question, we are mostly focusing on the forward main 
path. 
3.5. Text mining applications 
As already stated, main path analysis focuses on the structural configuration of a 
technological field and is still the method of choice for identifying the main directions of 
the field advancements. However, additional information provided by patent documents 
are typically neglected. Patent classes and titles of the patents on the main path provides 
us with general information on the main trends, however, not showing in the detail the 
topics and keywords, which are included in these patents.  Text mining mitigates this 
limitation by providing a rich tool-box for analyzing patent abstracts and technical 
descriptions.  
As patent documents are well-structured and provide sufficient information about 
the invention along with their abstracts and titles, text mining techniques are of help here. 
This method allows identifying patterns in the large scope of data (Yoon and Park, 2003). 
Text mining includes a large number of procedures and tasks and their implementation 
may vary from the type of data in use as well as aims of the analysis. As we are interested 
in the technological change of German pBT over time, analysis of frequencies of specific 
terms and topics over time is of high significance. In applying text mining we are following 
below-stated procedure (elaborated based on Yoon and Park, 2003 and Liang and Tan, 
2007): 
1. Choice of the relevant sample of patent data. In performing this step, we are 
taking the same patent data, as was used for main path analysis. In this, only 
German and English titles and abstracts from both focal and citing patent 
population were filtered out, with abstracts and titles written in German 
language being translated with the help of Deepl and Google Translate. As 
some patents´ titles or abstracts are missing in PATSTAT and some patents 
were applied in languages, different from English or German. 
2. Data preprocessing and transformation. This step included “tidying” and 
structuring data. Thus, stop words were removed from both titles and abstracts 
and stemming of the document was performed. Besides standard stop words, 
typical words of patent documents that are not describing the content of the 
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invention, were deleted from text, so that they do not bias results of the analysis 
(such as “invention”, “current”, “present” etc.6) Apart from that, numbers, being 
irrelevant for our case, were excluded from texts. On the next step words within 
each title and abstract are separated to make count easier.  
3. Identification of relevant patterns and their analysis. At this stage, term 
frequencies are calculated for the whole dataset as well as over time. Apart 
from that, trends of occurrence for several keywords identified with the help of 
main path and bioeconomy-related literature to be relevant or crucial for the 
transformation, are observed. These terms for our case included: "plant", 
"nucleic", "fatti", "acid", "transgen", "gene", "yield", "resist", "environment", 
"agricultur", "econom", "bioreactor", "cell", "tissu", "wound" and "vitro". 
Visualization of the results. In order to make results illustrative, they are visualized 
with the help of R Studio. The relevant codes are elaborated based on the book of Silge 
and Robinson, 2017. 
4. Main path analysis 
4.1. Descriptive statistics 
To start with, we turn our attention to general characteristics of patent data used 
for the purpose of this analysis. First of all, we are interested in analyzing the overall 
trends of patenting over time. Figure 1 presents the distribution for focal and citing 
patents for the entire observation period. The peak of initial patents, related to pBT, lies 
between 1998 and 2001, which corresponds to peak in the whole industry. The peak in 
citations corresponds to 2008 to 2012, with the most often citation lag of 5 to 8 years. 
This lag can explain the drop in the citation numbers in the last observation years. The 
citing peak occurs after decline in pBT patents. In the middle of 2000s the number of 
citing patents is starting to exceed pBT patent numbers. One possible explanation for 
that may be that citing patents spread in the fields other than pBT.  
 
 
                                               
 
6 Full list of the words: one", "also", "said", "say", "composition",  "process", "method", "invention", "current", 
"present", "relate", "summary", "use", "comprising", "sequence", "formula",  "allow", "allowing", "alter", 
"altering", "additionally", "agent", "agents", "activity", "activities", "usage", "well", "methods", "thereof", 
"encoding", "least", "absence", "comprises", "novel", "provided", "using", "including", "provide", "producing", 
"containing", "particularly", "preferably", "represent", "constructs", "useful", "optionally", "provided", "interest" 
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To gain in-depth insights into the composition and technological origin of citing 
patents, we checked, whether the citing patents originate from biotechnology. Thus IPC 
classes, assigned to citing patents, were checked for being biotechnology-related (list of 
biotechnology-related patent classes was presented in 3.2). Patents were classified as 
biotechnology patents whenever at least one biotech-related technology class appeared 
on the document. The results of the analysis are shown in figure 2. 
At the onset of the observation period, the large majority of citing patents is related 
to biotechnology. However, after the middle of the 2000s the picture is starting to change. 
For biotechnology-related patent citations, we observe a volatile trend line while non-
biotech patent citations increase continuously. In 2008 the number of non-biotech patent 
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that may lie in expected increased competition, coming from regulation change in the 
field of pharmaceuticals (Vermeulen, 2018). Thus, many pharma patents, which for sure 
can cite biotech ones, were applied at that time. The dominance of non-biotech patent 
citations in recent years implies that other technologies increasingly affected 
biotechnology in Germany. Figure 3 provides a fine-grained exploration of technological 
orientation for all non-biotechnology patent citations (figure 3). 
Interestingly, many of these technological classes relate to biocides and plant 
growth regulators (A01N43, A01N25, A01N47), i.e. classes which are highly relevant for 
increasing plant production and increasing yield. In other words, we can observe already 
at this stage of our exploration patterns which mirror a transition of biotechnology towards 
bioeconomy.  
Furthermore, we looked at the applicants, that contribute to the largest number of 
patents within the population. These actors include: BASF Plant Science GmbH (about 
22% of patents without accounting for subsidiaries). Apart from that, active was Bayer 
Cropscience AG (about 4,5% of patents), Max Planck Society (3,5% of patents) and 
Fraunhofer Society (about 3,2% of patents). When it comes to different types of SMEs, 
the most active here appeared to be Icon Genetics AG, which is now part of the Denka 
Company (more than 1,5% of patents) and Greenovation Biotech GmbH, which is now 
part of KAWA Beteiligungen GmbH (around 1% of patents). In addition, several new 
actors appear within the citing sample. Thus, Sungene & Company KGaA, a subsidiary 
of BASF Plant Science, has applied for more than 1% of patents or large corporation 
Suedzucker (0,5% of patents) were put forward along with SMEs Greenovation Biotech, 
Nomad Bioscience GmbH or Zellwerk GmbH (both around 0,1-0,7% of patents). 
Summing up, although the majority of patents were applied by big corporations, 
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important patents. In the next session, the main path within technological field will be 
defined and analyzed. 
4.2. General characteristics of the directed patent citation graph 
Insight from our descriptive analysis indicates a shift in pBT towards more 
sustainability-oriented topics. To substantiate this initial observation, we explore now the 
overall patent citation graph for the German pBT. 
Hence, we first construct a directed patent citation graph. Here, nodes are initial 
pBT patents identified, which are connected to citing patents´ nodes via citation tie. In 
general, the whole patent citation graph is constructed of 2138 nodes and 12198 ties. 
Not all initially identified patents were included in this graph. 581 patent families (40,5% 
of the overall population) did not receive any citation, thus being isolates. Figure 4 
illustrates the general citation graph, which, however, does not provide fine-grained 
information on the field structure. Nonetheless, it reveals some insightful patterns. The 
exploration shows one big component (1204 nodes, 56,31% of the whole graph), 
followed by a second relatively big component (303 nodes, 14,17% of the whole graph) 
and several smaller components (which in sum constitute 29,52% of the whole graph). 
Thus, one can state, that there are at least two large completely disconnected 
technological sub-fields, which dominated plant biotechnology in Germany over the last 
20 years. Therefore, further main path analysis would focus on these two big 
components. 
 
Figure 4: Patent citation graph in German biotechnology citation 
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Table 1 presents a selected number of key measures that allow us to draw 
conclusions about how the patents and their citations are concentrated and centralized. 
Table 1: General measures 
MEASURE VALUE 
DEGREE CENTRALIZATION      0.148 
OUT-CENTRAL      0.148 
IN-CENTRAL 0.034 





The overall patents citation graph is characterized by a rather low density which 
is typical for larger graphs. The average degree, defined as the average number of ties 
a node has, is almost five, meaning that outgoing ties are more frequent than incoming.  
The node level measure provides insights on the role of individual patents. In this, 
the looking at betweenness centrality is important. This measure reflects the number of 
times, the node lies on the shortest path between two other nodes (Borgatti et al., 2018). 
Thus, we can identify patents, which are working as the connectors in the citation graph, 
by bringing together two other inventions. These are 26007459- Monocotyledon plant 
cells and plants which synthesise modified starch; 38462357 - Process for the production 
of a fine chemical; 7867091 - New enzyme with starch synthase activity, useful for 
producing starch for foods and packaging materials; 42111699 - Soybean event 127 and 
methods related thereto. Thus, topics of modified plants and fine chemicals appear to be 
important within the scope of biotechnology. 
Considering two largest components and frequencies of patenting within them 
over time (Figure 5), one can see that the first (largest) component gains importance at 
the end of 2000s – beginning of 2010s. On the contrary, the importance of the second 
component remains relatively stable over time with a slight increase at the end of the 
2000s. By combining this data with patenting and citing statistics, one can state, that 
many of these patents are already the ones, coming outside of pBT. Thus, the 
investigation of main path may bring important insights here regarding where the field 
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Thus, we can generally see two main topics, that developed within the field. But 
what subjects exactly received the highest attention within the field and how did it 
develop over time? To answer this question main path analysis is applied in the next 
section. It allows us to zoom into the technological core development within one well-
specified sub-graph. 
4.3. Main path specification 
Now, we are interested in identifying the most influential trajectories along this 
patent citation graph. As already stated in part 3.4, we are using the search path count 
measure in order to identify the main path. Along with the aim of this paper, we are 
focusing on forward local main path7. As two big components could be found, main 
trajectories have to be found for both of them. In that case, we are expecting to have 
two separate topics, representing each of the components. Grouping of the main path 
patents over time accompanied by an evaluation of patents´ contents, allows us to 
identify three sequential phases of development inherent in each of two components. 
Figure 6 contains a forward local main path whereas table 2 contains titles of these 
applications. 
 
                                               
 
7 Backward main path as well as global main paths are also presented in the appendix B.  As can be seen 
there, in general global main path corresponds to the identified forward local main path, whereas backward 











Number of patents 1st component Number of patents 2nd component
Figure 5: Trend of number of patents across components over time 
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26018733 1995 Process for the production of a modified starch 
7815459 1996 Neue Nucleinsäuremoleküle aus Mais und ihre Verwendung zur 
Herstellung einer modifizierten Stärke (English: Nucleic acid molecules 
from corn and their use in the preparation of a modified starch) 
22318973 1998 Nucleic acid molecules from rice encoding an r1 protein and their use for 
the production of modified starch 
7910992 1999 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen 
und deren Verwendung für die Herstellung modifizierter Stärke (English: 
Nucleic acid molecules from wheat, transgenic plant cells and plants and 
their use in the production of modified starch) 
26007459 2000 Monocotyledon plant cells and plants which synthesise modified starch 
36607228 2004 Plants with increased activity of a starch phosphorylating enzyme 
37441320 2006 Genetically modified plants synthesizing starch with increased swelling 
power 
40352205 2009 Method for improved utilization of the production potential of transgenic 
plants introduction 
40380378 2009 Use of carboxamides on cultivated plants 
41319604 2009 Use of succinate dehydrogenase inhibitors for increasing the resistance of 
plants or parts of plants to abiotic stress 
43625381 2010 Use of fluopyram for controlling nematodes in nematode resistant crops 
43825341 2010 Active ingredient combinations comprising pyridylethylbenzamides and 
other active ingredients 
45509139 2010 Use of fluopyram for controlling nematodes in crops and for increasing 
yield 
45873472 2010 Use of active ingredients for controlling nematodes in nematode-resistant 
crops 
 
                                               
 
8 Here earliest filing year is included.  
Figure 6: Forward local main path 
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By looking at application titles and abstracts, one can distinguish several stages:  
 Stage one. End of 1990s-beginning of the 2000s. Researching on nucleic 
acid molecules and modified starch 
At the beginning of trajectory more general patents dealing with the description of 
nucleic acid molecules as well as methods of starch modification and production of 
transgenic plants. Thus, it can be stated that companies in Germany only started working 
on the topics of transgenic plants. Patents relate to maize, rice and wheat proteins and 
can thus be mostly related to green and not to white or red biotechnology. 
 Stage two. Middle of the 2000s. Evoking extraordinary properties. 
These patents start to work out how the developed genetically modified plants will 
be used in order to increase specific properties, e.g. “increasing swelling power” or 
“increase in the activity of a starch-phosphorylating OK1 protein”, being thus the middle 
ground between general initial research on nucleic acids and specific environment-
related research. 
 Stage three. End of the 2000s-2010s. Increasing yield, tolerance and 
resistance 
These patents come from just investigating specific plant properties towards their 
usage in specific climatic conditions, e.g. “draught” or increasing plant tolerance towards 
“abiotic stress” and increasing the production potential of a plant. Thus, this stage can 
be seen as the answer to the calls for nutrition provision and to harder climatic conditions.  
As for actors of the field, it can be seen, that it is created by big corporations 
(BASF, Aventis) and their subsidiaries. No SMEs or research institutions can be found 
along the path. Therefore, at this stage big players can be seen as technological agenda 
setters within the biggest biotechnology patent citations´ component9.  
Thus, by just looking at the patents and actors staying behind these applications, 
several conclusions can be made. First of all, the main topic of the biggest component 
concerns the topic of genetic plants. This topic is rather controversial when talking about 
sustainability issues and cannot be included into bioeconomy according to some streams 
of the views, which point out ethical issues concerning the field. However, here the 
development of the path is of a high interest. Whereas initial patents reflect rather basic 
research on the topic, which is further enriched by the applications of created genetically 
modified plants, later patents directly address the creation of more climatically-prone 
                                               
 
9 Apart from their power, these firms also possess financial resources, which make high amount of patents 
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plants, and this issue is without a doubt quite topical. Secondly, as the patents are 
created by big corporations, it can be suggested, that, although being registered also 
internationally/in Germany, these inventions are not directly oriented towards the 
German market. Despite this fact, the topic of genetically modified plants, set by big 
corporations, plays an important role for the German technology space. 
Thus, although giving the idea about the development of trajectory within the 
timeframe, at this point the question of transition towards bioeconomy based on the 
patent data cannot be answered univocally. Thus, we look at the second largest 








Figure 7: Forward local main path, 2nd component 
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7780015 1995 Cell cultivation process and assembly incorporates spirally-wound substrate 
belt 
7832571 1997 Cell culture apparatus for three=dimensional cell or tissue cultivation 
7903735 1999 Method for populating substrates with biological cells and populating 
devices that can be used therefor 
26055133 1999 System for the cultivation of cells or tissue has a culture container with 
capillary netting or matrix material around the cultivation zone to be fed 
with a consistent and gas-free culture medium 
7647965 2000 Bioreactor growing tissue or complete organ implants by assembly of 
differing cell types in specific forms and patterns, includes chambers with 
cavities of differing shape 
7689320 2001 Vorrichtung zur Druckperfusion für das Züchten und/oder für das 
Behandeln von Zellen (English: Device for pressure perfusion for culturing 
and/or treating cells) 
33495025 2003 Perfusionseinheit und Perfusionsstation zur Hautwundbehandlung sowie 
dessen Verwendung (English: Perfusion unit and perfusion station for 
treating skin wounds, and its use) 
34895251 2004 Inventive bioreactors and bioreactor systems 
41011042 2008 Perfusable bioreactor for the production and/or cultivation of a human or 
animal blood vessel and/or a human or animal tissue 
41060425 2008 Microbioreactor and microtiter plate comprising a plurality of 
microbioreactors 
41114371 2008 Perfusable bioreactor for the production of human or animal tissues 
41340603 2008 Bioreactor and method for cultivating cells and tissues 
42046448 2008 Device for physiological, dynamic in-vitro cell stretching 
42134087 2008 Method and device for the stimulation of cells 
44583592 2010 Microfluidic system and method for the operation thereof 
45090869 2010 Perfusion device 
54780052 2014 Device and method for identification of microorganisms 
53174852 2015 Wound care system 
53174853 2015 Wound dressing system 
54867177 2015 Modulares bioreaktorsystem (English: Modular bioreactor system) 
 
Figure 7 displays the main path for the second largest component. The main path 
is divided into two streams. The first stream is purely related to medical research, in 
particular with wound systems and in-vitro devices. The patterns identified here point to 
the close relatedness between biotechnology and medical research.  
The second stream is particularly interesting with regards to the aim of this paper. 
Along the trajectory we can find patents related to the topic such as operations on cells 
and tissues as well as bioreactors, each of which closely linked to medicine research. In 
most of the patents it is stated, that provided inventions can be important for oncology, 
obesity and wound healing. Apart from that, tissue cultivation may be important for the 
production of plants with new properties. Thus, this path provides a good example of 
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biological material usage for different industries, in this case medicine. This insight is in 
line with SDG3: Good health and well-being (Fraunhofer, 2018). 
Most interestingly, the technological advancements constituting the technological 
path displayed in Figure 7 also follow the stages identified for the largest component. 
General investigations of cell structure apparatus and bioreactors at the end of the 
1990s-beginning of the 2000s were further substituted by investigation of specific 
bioreactor systems and specific use of inventions identified before. At the end of the 
2000s these inventions were used for specific purposes – tissue engineering, cells 
stimulation. Thus, the same aims of increased yield or plant resistance here can be 
achieved with the help of alternative to transgenic plants methods, which means higher 
relevance for bioeconomy. Also important to mention is that main actors of the patents 
on this main path are not corporations, but universities, individuals and smaller firms. As 
consequence, here the topics of transgenic plants do not have such relevance as for the 
large corporations´ patents. What seems to be important for the German biotechnology 
space, is the development of medical research-related biotechnology into advanced 
usage of biomass for the purposes of healing of specific relevant illnesses. However, 
apart from that, tissue and cell engineering may be of high importance for the increased 
plant resistance. 
In summary, main path analysis allows us to detect and explore the technological 
core within pBT. The analysis can be applied to the largest components (but also other 
sub-graphs) of the patent citation graph. We found technological paths in the two largest 
components follow the same development stages, starting with the basic research, 
followed by application-based research, and finally sustainability-related inventions. 
4.4. Exploration of patent space with text mining tools 
In order to detect topics, which occur in the patents at most, abstracts are 
analyzed using text mining tools implemented in R10. In the first place, we are interested 
in analyzing the whole patent space in order to find out particular terms that are of major 
importance for the industry and their trends over time. Thus, all identified 2083 patent 
families were analyzed (titles + abstracts). The most frequent terms (more than 1000 
occurrences) are present in figure 811.  
 The aim of this analytical exercise is to conduct a content-based exploitation 
using the entire patent population to identify the most relevant topics and their 
development over time. Focus on two biggest components allows us to separate most 
influential technological trends within the industry, based on the limited amount of 
                                               
 
10 https://www.rstudio.com/ 
11 Correspondent wordcloud can be found in appendix C. 
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patents. To be sure, that our claim regarding trends towards increased plant tolerance 
and resistance as well as tissue engineering techniques, are also relevant for the industry 
in general, we have to take periphery patents into account as well.  
Figure 8 presents the most frequently appearing terms along with patent 
population. Our exploration indicates a high relevance of the topic ‘transgenic plants’. 
This is supported by the appearance of such terms as “dna”, “transgen”, “express”. Apart 
from that, “yield”, “enhanc…”12, “increas…” also appear to be among the terms with high 
frequencies, which outlines the overall importance of the patents along the first 
component´s main path. No terms related to the topic of tissue engineering or cells 
cultivation are present. However, it is interesting to look at the appearance of these terms 
over time and to see, whether their relative importance has changed. 
To do so, we look at the terms, relevant for topics of our interest (two main paths 
topics) as well as sustainability-related terms. The latter would favor the development of 
the field towards bioeconomy. Thus, we choose the terms which appeared to be 
important after descriptive and main path analysis, and analyzed changes of their 
relevance over time. The term "plant" points to the relevance of selected patents for pBT. 
Such terms as "nucleic","fatti", "acid", "transgen" and "gene" are relevant for the main 
path coming from the largest component. Terms "yield", "resist", "environment" and 
"agricultur", which play significant role along later stages of the path. The term "econom" 
may reflect importance of economic view on bioeconomy, which outlines the necessity 
                                               
 
12 Terms obtained as the result of stemming.  
Figure 8: Most frequent terms, all patent families 
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of inventions to be economically relevant. Terms "bioreactor", "cell", "tissu", "wound" and 
"vitro" represent two branches of the second component´s main path. Figure 9 presents 
frequencies of these terms over time. All frequencies presented are shown in relative 
values by dividing the number of patents, in which a specific term occurs in a specific 
year, through all patents, that were filed in that year. 
One important conclusion is the decrease of all terms, connected to the 
transgenic plants, thus, reflecting main path of the first (largest component). Terms 
“Nucleic","fatti", "acid", "transgen" and "gene" lose importance in the mid-2000s. 
Additionally, the topic of yield increase (terms "yield", "resist", "environment" and 
"agricultur"), gain in importance by the end of 2000s-beginning of 2010s. All terms, 
related to this group ("bioreactor", "cell", "tissu", "wound" and "vitro"), are the only ones 
that increased in relevant terms over last period.   
The patterns described above provide us with some interesting insights, which 
become not directly apparent when conducting a main path analysis. First, the main 
component related to the topic of transgenic plants, seems to lose its dominance over 
time. This happens, although the main component in general consists of more than half 
of the overall graph´s nodes. The only sub-topics, which are still developed within this 
path, relate to ‘increased yield’ and ‘tolerance of the plants’. However, even these themes 
did not receive further attention in Germany during the last several years. Second, 
research institutes and small firms gained in importance, which is reflected in the relative 
increase of attention towards the topic of cell cultivation. Derivatives, produced along this 
Figure 9: Frequencies of specific terms over time 
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path, may present real importance for the future of medicine and in its broad sense to 
bioeconomy.  
Thus, the overall analysis shows that pBT in Germany changed its research 
orientation. At the onset, we uncover a strong research focus in pBT on transgenic 
plants. The patent documents substantiating this finding are held by a small number of 
very large corporations. Now the field gains diversity by putting forward such topics as 
sustainability, resistance towards hard climatic conditions, healing with the help of 
biological material. Main path analysis revealed the existence of two dominant 
components within the field: the largest component related to transgenic research, and 
the smaller one, related to cell cultivation. These different paths, however, follow the 
same stages of development: from general investigations through first applications 
towards evoking of new extraordinary properties of research subjects. Both paths seem 
to develop in line with SDGs, which suggests their importance for the German 
bioeconomy. 
5. Discussion and conclusion 
This paper provides new empirical evidence and insights on technological field 
evolution by exploring the transition from biotechnology innovations towards the 
emergence of bioeconomy over time. Main path analysis can bring important insights 
into the evolution of a particular field by pointing out main trajectories. The results of this 
paper may not only be used for the particular field of pBT but also enrich main path 
methodology by distinguishing the differences in the technological path that specific 
categories of firms (here SMEs) main take. Apart from that, the paper adds on the 
discussion on transgenic plants and inventions regarding them made by German firms.  
Main path analysis, extended by content analysis, has shown, that there exist two 
main components of patents, orchestrated by different kind of actors. The larger 
component, probably with orientation on international markets, has the main topic of 
transgenic plants research. It is created by a small number of large corporations. Smaller 
component is led by smaller firms and research institutions. It relates to the topic of cells 
cultivation and bioreactors and applies to the usage of biomaterials in medical research. 
Over time the second topic seems to gain more relative weight. All in all, it can be said, 
that the patents of the firms are moving towards answering the challenges, voiced by 
Sustainable Development Goals (SDGs), in particular goal two “Zero hunger” and goal 
3 “Good health and well-being” as well as National Research Strategy BioEconomy 
2030, which sees Securing global nutrition as one of the most important actions. The 
paper thus provides important implications to policy-makers regarding the execution of 
strategies action plans. In addition to that, it also gives insights into the differences in 
patenting patterns of SMEs and purely German research institutions and big 
corporations. SMEs thus may profit from engaging in cooperation with research 
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institution as well as from fining niche topics within biotechnology spectrum. The paper 
also provides insights to the discussion on technological trajectories. It shows the 
importance of going beyond main component, especially in the case of the presence of 
several big players in the field. Apart from that, it outlines value added from conducting 
content analysis on the whole patent population, which helps to identify relevant trends. 
Nevertheless, there still remains enough room for future research. First, several 
methods to define technological classes related to pBT can be used to prove the 
robustness of results. As noted in Shubbak (2018) apart from combined keywords and 
IPC analysis, firm population or expert advice can be used. Thus, a broader picture of a 
not yet officially defined subfield can be brought. Furthermore, although the research 
questions stated in the article, already limits itself to a specific subfield within 
biotechnology, pBT may still be too broad for the main path identification. Additional 
research may be performed, which limits itself to a specific technology within pBT, e.g. 
tissue culture. Therefore, more specific trajectories and important patents may be 
observed. As this paper aims at providing the overall picture of the field, no deeper 
analysis of each patent class was provided, however, it may serve as an interesting 
implication for those, willing to go deeper in the subfield analysis. Besides, the paper is 
limited to the usage of patent data as the indicator of innovative activity of the field. It is 
also stated, that for the field of biotechnology in general patents can serve as such an 
indicator. However, the complementary usage of alternative indicators and data sources, 
e.g. citations of scientific literature, may enrich the picture of pBT. Apart from that, 
important limitation of the paper lies in the absence of commercial value of patents in the 
analysis. The presence of this data would enable realizing whether the patents belonging 
to second component (medical and more bio-related) bring the same end-value as DNA-
related ones. Also worth mentioning are the possible extensions of text mining tools, 
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Appendix A: Chosen technology classes, IPC 





A01H 1* Processes for modifying genotypes (A01H 4/00 takes precedence) 
A01H 4* Plant reproduction by tissue culture techniques 
A61K 38/56 Medicinal preparations containing peptides (peptides containing beta-
lactam rings A61K 31/00; cyclic dipeptides not having in their molecule any 
other peptide link than those which form their ring, e.g. piperazine-2,5-
diones, A61K 31/00; ergoline-based peptides A61K 31/48; containing 
macromolecular compounds having statistically distributed amino acid 
units A61K 31/74; medicinal preparations containing antigens or antibodies 
A61K 39/00; medicinal preparations characterised by the non-active 
ingredients, e.g. peptides as drug carriers, A61K 47/00) … from plants 
C07K 4/10 Peptides having up to 20 amino acids in an undefined or only partially 
defined sequence; Derivatives thereof... from plants 
C07K 14/415 Peptides having more than 20 amino acids; Gastrins; Somatostatins; 
Melanotropins; Derivatives thereof… from plants 
C07K 16/16 Immunoglobulins, e.g. monoclonal or polyclonal antibodies… against 
material from plants 
C12M 3* Tissue, human, animal or plant cell, or virus culture apparatus 
C12N 5* Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; 
Cultivation or maintenance thereof; Culture media therefor (plant 
reproduction by tissue culture techniques A01H 4/00) 
C12N 9/32 Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof (preparations 
containing enzymes for cleaning teeth A61K 8/66, A61Q 11/00; medicinal 
preparations containing enzymes or proenzymes A61K 38/43; enzyme 
containing detergent compositions C11D); Processes for preparing, 
activating, inhibiting, separating, or purifying enzymes… Alpha-amylase 
from plant source 
C12N 15/05 Mutation or genetic engineering; DNA or RNA concerning genetic 
engineering, vectors, e.g. plasmids, or their isolation, preparation or 
purification; Use of hosts therefor (mutants or genetically engineered 
microorganisms C12N 1/00, C12N 5/00, C12N 7/00; new plants A01H; 
plant reproduction by tissue culture techniques A01H 4/00; new animals 
A01K 67/00; use of medicinal preparations containing genetic material 
which is inserted into cells of the living body to treat genetic diseases, gene 
therapy A61K 48/00; peptides in general C07K… Plant cells 
C12N 15/29 … genes encoding plant proteins, e.g. thaumatin 
C12N 15/82 … for plant cells 
C12Q 1/6895 Measuring or testing processes involving enzymes, nucleic acids or 
microorganisms (measuring or testing apparatus with condition measuring 
or sensing means, e.g. colony counters, C12M 1/34); Compositions 
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A01N 43 Biocides, pest repellants or attractants, or plant growth regulators 
containing heterocyclic compounds (containing cyclic anhydrides, cyclic 
imides A01N 37/00; containing compounds of the formula fig11, 
containing only one heterocyclic ring, wherein m≥1 and n≥0 and fig12 is 
unsubstituted or alkylsubstituted pyrrolidine, piperidine, morpholine, 
thiomorpholine, piperazine or a polymethyleneimine with four or more 
CH2 groups A01N 33/00-A01N 41/12; containing cyclopropane carboxylic 
acids or derivatives thereof, e.g. esters having heterocyclic rings, A01N 
53/00) 
A01P 3 Fungicides 
A01N 37 Biocides, pest repellants or attractants, or plant growth regulators 
containing organic compounds containing a carbon atom having three 
bonds to hetero atoms with at the most two bonds to halogen, e.g. 
carboxylic acids (containing cyclopropane carboxylic acids or derivatives 
thereof, e.g. cyclopropane carboxylic acid nitriles, A01N 53/00) 
A01P 7 Arthropodicides 
A01N 25 Biocides, pest repellants or attractants, or plant growth regulators, 
characterised by their forms, or by their non-active ingredients or by their 
methods of application (fungicidal, bactericidal, insecticidal, disinfecting 
or antiseptic paper D21H); Substances for reducing the noxious effect of 
the active ingredients to organisms other than pests 
C07D 401 Heterocyclic compounds containing two or more hetero rings, having 
nitrogen atoms as the only ring hetero atoms, at least one ring being a six-
membered ring with only one nitrogen atom 
A01N 47 Biocides, pest repellants or attractants, or plant growth regulators 
containing organic compounds containing a carbon atom not being 
member of a ring and having no bond to a carbon or hydrogen atom, e.g. 
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Appendix B: Additional main path explorations 








26006195 1999 Plants expressing delta 6-desaturase genes and oils from these plants 
containing pufas and method for producing unsaturated fatty acids 
27213647 2000 Novel elongase gene and method for producing multiple-unsaturated 
fatty acids 
29224898 2002 Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in 
Pflanzen (English: Process for the preparation of polyunsaturated 
fatty acids in plants) 
32920641 2003 Method for the production of polyunsaturated fatty acids 
33132668 2003 Novel plant acyltransferases specific for long-chained, multiply 
unsaturated fatty acids 
34120175 2003 Method for the production of multiply-unsaturated fatty acids in 
transgenic organisms 
34894872 2004 Method for producing unsaturated omega-3 fatty acids in transgenic 
organisms 
35911218 2004 Method for producing polyunsaturated fatty acids in transgenic 
organisms 
38857863 2006 Processes for producing polyunsaturated fatty acids in transgenic 
organisms 
43084431 2009 Regulatory nucleic acid molecules for enhancing seed-specific gene 
expression in plants promoting enhanced polyunsaturated fatty acid 
synthesis 
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26018733 1995 Process for the production of a modified starch 
7815459 1996 Neue Nucleinsäuremoleküle aus Mais und ihre Verwendung zur Herstellung 
einer modifizierten Stärke (English: Nucleic acid molecules from corn and 
their use in the preparation of a modified starch) 
22318973 1998 Nucleic acid molecules from rice encoding an r1 protein and their use for the 
production of modified starch 
7910992 1999 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen 
und deren Verwendung für die Herstellung modifizierter Stärke (English: 
Nucleic acid molecules from wheat, transgenic plant cells and plants and 
their use in the production of modified starch) 
26007459 2000 Monocotyledon plant cells and plants which synthesise modified starch 
36607228 2004 Plants with increased activity of a starch phosphorylating enzyme 
37441320 2006 Genetically modified plants synthesizing starch with increased swelling 
power 
40380378 2008 Use of carboxamides on cultivated plants 
40352205 2009 Method for improved utilization of the production potential of transgenic 
plants introduction 
41319604 2009 Use of succinate dehydrogenase inhibitors for increasing the resistance of 
plants or parts of plants to abiotic stress 
43625381 2010 Use of fluopyram for controlling nematodes in nematode resistant crops 
43825341 2010 Active ingredient combinations comprising pyridylethylbenzamides and 
other active ingredients 
45509139 2010 Use of fluopyram for controlling nematodes in crops and for increasing yield 
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7666720 2000 Verfahren und Vorrichtung zur Herstellung von biologischem 
Gewebe in einer Wachstumskammer (English: Method and 
apparatus for producing biological tissue in a growth chamber) 
7712173 2002 Vorrichtung zum Züchten oder Kultivieren von Zellen in einem 
dosenartigen Behälter (English: Device for growing or cultivating 
cells in a can-like container) 
7751205 1995 Appts. for measuring contractile force of muscle tissue 
7802112 1996 New micro-gravitational cell culture assembly 
7823408 1997 Biotechnological reaction vessel for breeding microorganisms 
7858958 1998 Tissue engineering procedure extracting and culturing cells with 
mechanical stimulation to simulate in-vivo growth 
34484964 2003 Verfahren und Bioreaktor zum Kultivieren und Stimulieren von 
dreidimensionalen, vitalen und mechanisch widerstandsfähigen 
Zelltransplantaten (English: Method and bioreactor for culturing 
and stimulating three-dimensional, vital and mechanically 
resistant cell transplants) 
41011042 2008 Perfusable bioreactor for the production and/or cultivation of a 
human or animal blood vessel and/or a human or animal tissue 










#2002 Bremen Papers on Economics & Innovation 
 
From biotech to bioeconomy 
New empirical evidence on the technological transition to plant-based bioeconomy based on patent 
data 
 






7780015 1995 Cell cultivation process and assembly incorporates spirally-wound substrate 
belt 
7832571 1997 Cell culture apparatus for three=dimensional cell or tissue cultivation 
7903735 1999 Method for populating substrates with biological cells and populating 
devices that can be used therefor 
7689320 2001 Vorrichtung zur Druckperfusion für das Züchten und/oder für das 
Behandeln von Zellen (Engish: Device for pressure perfusion for the 
cultivation and/or treatment of cells) 
41340603 2003 Bioreactor and method for cultivating cells and tissues 
34895251 2004 Inventive bioreactors and bioreactor systems 
45090869 2010 Perfusion device 
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Appendix C. Additional text mining result 
Word cloud, all patents 
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